ECM1 and neoplasm: Overall, our study reveals the molecular mechanism by which osteoblast‐secreted ECM1 in the bone microenvironment under anti‐androgen therapy pressure drives tumor resistance through the ECM1/ENO1/MAPK signaling axis in BMPC.